1.
Shabbir S, Humayun Z- e-, Yousaf MJ, Manzar MA, Mushtaq S, Yousaf M. COMPARISON OF LIPID LOWERING EFFECTS OF ROSUVASTATIN AND ATORVASTATIN IN TYPE 2 DIABETIC PATIENTS WITH PRIMARY HYPERLIPIDEMIA. PAFMJ [Internet]. 2020 Dec. 15 [cited 2024 Mar. 29];70(6):1671-75. Available from: https://pafmj.org/PAFMJ/article/view/5866